MedTrace Logo

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

NCT04520698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1322

Last updated 2025-10-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate a comprehensive model for integrating both primary and specialty Palliative Care for older adults with dementia into nursing facilities. Palliative Care is a supportive care approach that aims to improve the quality of life of patients and their families facing serious or life-threatening illnesses, through the prevention and relief of suffering through the treatment of pain and other problems, using physical, psychosocial and spiritual approaches. Palliative care is specialized medical care for people who are living with a serious illness. This type of care is focused on providing relief from the symptoms and from the stress of the illness. The goal is to improve quality of life for both patient and family.

The UPLIFT-AD model will include providing education on primary Palliative Care for residents with dementia to nursing facility staff, training nursing facility staff in providing primary Palliative Care, and providing access to specialty Palliative Care consultations for residents. To help understand the impact of these interventions, this study will also collect information about resident health, the care they receive, and perceptions of their quality of life according to both family members and nursing facility staff.

Conditions

  • Alzheimer Disease

Interventions

BEHAVIORAL

UPLIFT-AD

Access to palliative care needs screening, advance care planning conversations, palliative care consultations

Sponsors & Collaborators

  • University of Maryland, Baltimore

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Kathleen T Unroe, MD, MHA · Indiana University

  • John Cagle, PhD, MSW · University of Maryland, Baltimore

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-08
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04520698 on ClinicalTrials.gov